Mark Nelson
Net worth: 40 M $ as of 31/08/2026
Net worth: 40 M $ as of 31/08/2026
Mark Nelson is the founder of DFO Investments Pty Ltd., established in 1992, holding the title of Executive Chairman.
Current jobs include Co-Chairman at Art Gallery of New South Wales; Chairman at Art Exhibitions Australia Ltd. since 2019; Director at Kaldor Public Art Projects since 2005; Independent Non-Executive Director at Telix Pharmaceuticals Ltd. since 2017; Director at The Mindgardens Neuroscience Network since 2018; Director at Caledonia Foundation Pty Ltd. since 2002; and Member-Governors Board at The Florey Institute of Neuroscience & Mental Health since 2007.
Education history includes undergraduate and doctorate degrees from the University of Melbourne and a graduate degree from the University of Cambridge.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/03/2026 | 3,628,750 ( 1.07% ) | 40 M $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Director/Board Member | 01/09/2026 |
DFO Investments Pty Ltd.
DFO Investments Pty Ltd. Investment ManagersFinance DFO is an active, conservative manager which constructs concentrated equity portfolios that seeks to achieve absolute returns over a long-term time horizon predominantly by investing in publicly-listed Australian companies. They typically apply an investment approach that combines growth criteria with value disciplines (growth at value). | Founder | 01/01/1992 |
Art Gallery of New South Wales
Art Gallery of New South Wales Other Consumer ServicesConsumer Services Operates as an art museum | Chairman | - |
Kaldor Public Art Projects
Kaldor Public Art Projects Miscellaneous Commercial ServicesCommercial Services Provides art education services | Director/Board Member | 01/10/2005 |
Art Exhibitions Australia Ltd. | Chairman | 01/02/2019 |
Caledonia Foundation Pty Ltd.
Caledonia Foundation Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates philanthropic foundation | Director/Board Member | 01/08/2002 |
The Florey Institute of Neuroscience & Mental Health
The Florey Institute of Neuroscience & Mental Health Miscellaneous Commercial ServicesCommercial Services Operates as brain research center | Director/Board Member | 01/10/2007 |
The Mindgardens Neuroscience Network | Director/Board Member | 01/02/2018 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
DFO Investments Pty Ltd.
DFO Investments Pty Ltd. Investment ManagersFinance DFO is an active, conservative manager which constructs concentrated equity portfolios that seeks to achieve absolute returns over a long-term time horizon predominantly by investing in publicly-listed Australian companies. They typically apply an investment approach that combines growth criteria with value disciplines (growth at value). | Finance |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Art Gallery of New South Wales
Art Gallery of New South Wales Other Consumer ServicesConsumer Services Operates as an art museum | Consumer Services |
Kaldor Public Art Projects
Kaldor Public Art Projects Miscellaneous Commercial ServicesCommercial Services Provides art education services | Commercial Services |
Art Exhibitions Australia Ltd. | |
Caledonia Foundation Pty Ltd.
Caledonia Foundation Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates philanthropic foundation | Miscellaneous |
The Florey Institute of Neuroscience & Mental Health
The Florey Institute of Neuroscience & Mental Health Miscellaneous Commercial ServicesCommercial Services Operates as brain research center | Commercial Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
The Mindgardens Neuroscience Network |
Select your edition
All financial news and data tailored to specific country editions